Condition: Breast Cancer · Sponsor: Therapixel
The goal of this clinical trial is to compare, for the second reading of screening mammograms, the standard of care with an AI assisted scenario. The main questions it aims to answer are: * will the experimental pathway be non-inferior to the standard pathway? * will the experimental pathway be economically superior to the standard pathway? Participants will receive screening mammograms, as part of the breast cancer screening program. Researchers will compare the interpretation made by the second reader in the standard pathway with the AI assisted interpretation made by a different reader in the experimental pathway.
This description comes directly from the study's public registry record.
Brigitte Seradour · 06 09 88 38 64 · brigitteseradour@hotmail.fr
Patrice Heid · 06 09 07 83 67 · p.heid@depistage-cancerssud.org
Always discuss trial participation with your own doctor first.
| Centre de radiologie Les Défensions | Aubagne, France | Recruiting |
| Var Imagerie Medicale | Draguignan, France | Recruiting |
| VAR IMAGERIE MEDICALE - Centre d'Imagerie Médicale Le Clipper | Fréjus, France | Recruiting |
| VAR IMAGERIE MEDICALE - Clinique Les Lauriers | Fréjus, France | Recruiting |
| Cabinet de Radiologie du Cabot | Marseille, France | Completed |
| Centre de Sénologie Mermoz | Marseille, France | Recruiting |
| VAR IMAGERIE MEDICALE - Centre d'Imagerie Médicale Epsilon | Saint-Raphaël, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05800132